we report the case of a 44-year-old male affected by life-long, severe and recalcitrant form of atopic dermatitis (AD), with various atopic comorbidities. Multiple systemic therapies had been performed before our first observation, all interrupted for ineffectiveness. On May 2018, the patient recorded an Eczema Area and Severity Index (EASI) of 52, Peak Pruritus Numerical Rating Scale (NRS) of 8, and Dermatology Life Quality Index (DLQI) of 20. Blood exams showed a significant increased of total immunoglobulin E (IgE) plasma levels (5321 kUa/L; 0,00-100,00 kUa/L reference range).
An acute spondyloarthritis during successful treatment with dupilumab for severe atopic dermatitis
Raimondo, A
;Guglielmi, G;Lembo, S
2021-01-01
Abstract
we report the case of a 44-year-old male affected by life-long, severe and recalcitrant form of atopic dermatitis (AD), with various atopic comorbidities. Multiple systemic therapies had been performed before our first observation, all interrupted for ineffectiveness. On May 2018, the patient recorded an Eczema Area and Severity Index (EASI) of 52, Peak Pruritus Numerical Rating Scale (NRS) of 8, and Dermatology Life Quality Index (DLQI) of 20. Blood exams showed a significant increased of total immunoglobulin E (IgE) plasma levels (5321 kUa/L; 0,00-100,00 kUa/L reference range).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
